Immunity Boosting Treatment Enhances CAR-T Cell Therapy for Blood Cancers Advances in cellular immunotherapy that spur genetically modified T cells to attack cancer cells have revolutionized the treatment of certain blood cancers. Six such CAR-T cell therapies are approved by the Food and Drug Administration to treat certain types of
Pfizer-BioNTech Shot for Children Under 5 Safe and Effective, FDA Staff Says Food and Drug Administration staff said Sunday the coronavirus vaccine made by Pfizer and its German partner, BioNTech, for children younger than 5 is effective in producing a virus-blocking response and did not raise safety concerns, a prelude
ADA: Beta Bionics' Automated Insulin Pump Slashes Glucose Levels, Diabetes Distress in Type 1 Patients Artificial pancreases took center stage at this year’s annual meeting of the American Diabetes Association, with Medtronic, Insulet and more touting clinical trial successes for components of their respective closed-loop insulin delivery systems. Read more...
Joining the Fight Against Non-small Cell Lung Cancer In a recent study, researchers at the University of Missouri are identifying new minimally invasive biomarkers to develop a blood test for early detection of non-small cell lung cancer (NSCLC), one of two main types of lung cancer. This blood test also
Madhuri Manpadi, Ph.D. May’s WISER Woman is Madhuri Manpadi, Ph.D., Associate Professor in the Department of Chemistry and Physics at Drury University. Dr. Manpadi’s research involves designing and synthesizing libraries of novel compounds that are screened for anticancer activity. She shares her love of research with her
Haval Shirwan, PHD Haval Shirwan, PHD, is a Professor of Child Health, and Professor of Molecular Microbiology and Immunology, at University of Missouri School of Medicine. The primary focus of Dr. Shirwan’s translational research program at is to develop safe and practical immunomodulatory approaches with applications to
Gene Therapy’s Comeback: How Scientists are Trying to Make It Safer After years of disappointment, gene-therapy research has undergone a renaissance, with several high-profile drug approvals and a string of promising clinical-trial results against devastating genetic diseases, including sickle-cell disease and some blood cancers. Read more...
Abnormal Development of Brain’s Visual System May Contribute to Autism A research team, led by Washington University School of Medicine in St. Louis and the University of North Carolina (UNC) School of Medicine, has identified abnormalities in the development of the brain’s visual system in infants that may predispose them
Genetic Roots of 3 Mitochondrial Diseases ID’d Via New Approach When something goes wrong in mitochondria, the tiny organelles that power cells, it can cause a bewildering variety of symptoms such as poor growth, fatigue and weakness, seizures, developmental and cognitive disabilities, and vision problems. The culprit could be a
Adriana Montaño, Ph.D. Meet, Adriana Montaño, Ph.D., Associate Professor in the Department of Pediatrics at Saint Louis University. Dr. Montaño is developing enzyme replacement therapy, gene therapy, and other treatments for Morquio Disease, a rare, progressive, inherited disease. Her enzyme replacement therapy for patients suffering from Morquio
